Report cover image

NAD+ Enhancer - Global Industry Market Analysis Report 2020-2031

Publisher Paco Research
Published Jul 01, 2025
Length 127 Pages
SKU # PACO20149198

Description

NAD + enhancers are a class of substances that can increase the level of nicotinamide adenine dinucleotide (NAD +) in organisms. As a vital coenzyme, NAD + is widely involved in metabolic reactions in cells and plays a key role in maintaining the normal function and vitality of cells. However, with the increase of age, bad living habits and some disease factors, the level of NAD + in the human body will gradually decrease, which may lead to a series of problems such as cell function decline and metabolic disorders. NAD + enhancers are developed to solve this problem.

From the perspective of mechanism of action, NAD + enhancers mainly work by supplementing NAD + precursors. Common NAD + precursors include nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), etc. These precursors can be efficiently absorbed by cells and converted into NAD + through a series of enzymatic reactions in the body, thereby increasing the level of NAD + in cells. For example, after NMN enters the cell, it is rapidly converted into NAD + under the action of nicotinamide mononucleotide adenosyltransferase, and participates in important physiological processes such as cell energy metabolism and DNA repair.

NAD + enhancers have a variety of potential benefits. In terms of energy metabolism, they can improve the energy production efficiency of cells and enhance the body's endurance and vitality. Studies have shown that after supplementing with NAD + enhancers, the athletic ability of experimental animals has been significantly improved and fatigue has been reduced. In terms of cell repair and regeneration, it helps to promote DNA damage repair, maintain the stability of the cell genome, and delay cell aging. At the same time, it may also have a positive impact on cardiovascular health, improve endothelial function, and reduce the risk of cardiovascular disease. In addition, in terms of the nervous system, NAD + enhancers may help improve cognitive function and alleviate the symptoms of neurodegenerative diseases.

In terms of application scenarios, NAD + enhancers are mainly used in the field of health care. Many people who pursue a healthy life and delay aging will choose to take NAD + enhancers as daily nutritional supplements. At the same time, for some patients with chronic diseases such as diabetes, cardiovascular disease, etc., NAD + enhancers may also be used as an auxiliary treatment to help improve their condition. In the field of scientific research, NAD + enhancers are widely used in cell experiments and animal experiments to deeply study the mechanism of action of NAD + in various physiological and pathological processes.

As people pay more and more attention to health and anti-aging, the market prospects of NAD + enhancers are very broad. In the future, researchers will focus on developing safer and more efficient NAD + enhancer products. On the one hand, by optimizing the formula and production process of precursor substances, their bioavailability and stability will be improved. On the other hand, in-depth research will be conducted on the relationship between NAD + and various diseases, and the application potential of NAD + enhancers in more disease treatment fields will be explored to provide more protection for human health.

Report Scope

This report aims to deliver a thorough analysis of the global market for NAD+ Enhancer, offering both quantitative and qualitative insights to assist readers in formulating business growth strategies, evaluating the competitive landscape, understanding their current market position, and making well-informed decisions regarding NAD+ Enhancer.

The report is enriched with qualitative evaluations, including market drivers, challenges, Porter’s Five Forces, regulatory frameworks, consumer preferences, and ESG (Environmental, Social, and Governance) factors.

The report provides detailed classification of NAD+ Enhancer, such as type, etc.; detailed examples of NAD+ Enhancer applications, such as application one, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report provides detailed classification of NAD+ Enhancer, such as Capsules, Arm Transdermal Patch, Infusion Fluids, Nasal Spray, Sublingual Tablets, Other, etc.; detailed examples of NAD+ Enhancer applications, such as Hospitals, Clinics, Research Institutes, Other, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report covers key global regions—North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa—providing granular, country-specific insights for major markets such as the United States, China, Germany, and Brazil.

The report deeply explores the competitive landscape of NAD+ Enhancer products, details the sales, revenue, and regional layout of some of the world's leading manufacturers, and provides in-depth company profiles and contact details.

The report contains a comprehensive industry chain analysis covering raw materials, downstream customers and sales channels.

Core Chapters

Chapter One: Introduces the study scope of this report, market status, market drivers, challenges, porters five forces analysis, regulatory policy, consumer preference, market attractiveness and ESG analysis.
Chapter Two: market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: NAD+ Enhancer market sales and revenue in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter Four: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Five: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales, revenue, market share, footprint, merger, and acquisition information, etc.
Chapter Six: Provides profiles of leading manufacturers, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction.
Chapter Seven: Analysis of industrial chain, key raw materials, customers and sales channel.
Chapter Eight: Key Takeaways and Final Conclusions
Chapter Nine: Methodology and Sources.

Table of Contents

127 Pages
1 NAD+ Enhancer Market Overview and Qualitative Analysis
1.1 NAD+ Enhancer Product Definition and Statistical Scope
1.2 NAD+ Enhancer Market Status and Outlook
1.2.1 NAD+ Enhancer Market Revenue Estimates and Forecasts 2020-2031
1.2.2 NAD+ Enhancer Market Sales Estimates and Forecasts 2020-2031
1.3 NAD+ Enhancer Market Driver Analysis
1.4 NAD+ Enhancer Market Challenges Analysis
1.5 Porter's Five Forces Analysis
1.5.1 Bargaining Power of Suppliers
1.5.2 Bargaining Power of Buyers/Consumers
1.5.3 Threat of New Entrants
1.5.4 Threat of Substitute Products
1.5.5 Intensity of Competitive Rivalry
1.6 Regulatory Policy Analysis
1.7 Consumer Preference Analysis
1.8 Market Attractiveness Analysis
1.9 ESG (Environmental, Social and Governance) Analysis
2 NAD+ Enhancer Market Type Estimates & Trend Analysis
2.1 NAD+ Enhancer Type Dashboard
2.2 NAD+ Enhancer Market by Type
2.2.1 Capsules
2.2.2 Arm Transdermal Patch
2.2.3 Infusion Fluids
2.2.4 Nasal Spray
2.2.5 Sublingual Tablets
2.2.6 Other
2.3 Global NAD+ Enhancer Market Size by Type
2.3.1 Historical Analysis of the Global NAD+ Enhancer Market Size by Type (2020-2025)
2.3.2 Projected Analysis of Global NAD+ Enhancer Market Size by Type (2026–2031)
3 NAD+ Enhancer Market Geography Estimates & Trend Analysis
3.1 NAD+ Enhancer Geography Dashboard
3.2 Global NAD+ Enhancer Historic Market Size by Region
3.2.1 Global NAD+ Enhancer Market Sales by Region (2020-2025)
3.2.2 Global NAD+ Enhancer Market Revenue by Region (2020-2025)
3.3 Global NAD+ Enhancer Forecasted Market Size by Region
3.3.1 Global NAD+ Enhancer Market Sales by Region (2026-2031)
3.3.2 Global NAD+ Enhancer Market Revenue by Region (2026-2031)
3.4 North America NAD+ Enhancer Market by Country
3.4.1 North America NAD+ Enhancer Market Sales by Country (2020-2031)
3.4.2 North America NAD+ Enhancer Market Revenue by Country (2020-2031)
3.4.3 United States NAD+ Enhancer Market Sales, Revenue and Growth Rate (2020-2031)
3.4.4 Canada NAD+ Enhancer Market Sales, Revenue and Growth Rate (2020-2031)
3.5 Europe NAD+ Enhancer Market by Country
3.5.1 Europe NAD+ Enhancer Market Sale by Country (2020-2031)
3.5.2 Europe NAD+ Enhancer Market Revenue by Country (2020-2031)
3.5.3 Germany Market Sales, Revenue and Growth Rate (2020-2031)
3.5.4 France Market Sales, Revenue and Growth Rate (2020-2031)
3.5.5 U.K. Market Sales, Revenue and Growth Rate (2020-2031)
3.5.6 Italy Market Sales, Revenue and Growth Rate (2020-2031)
3.5.7 Spain Market Sales, Revenue and Growth Rate (2020-2031)
3.6 Asia-Pacific NAD+ Enhancer Market by Region
3.6.1 Asia-Pacific NAD+ Enhancer Market Sales by Region (2020-2031)
3.6.2 Asia-Pacific NAD+ Enhancer Market Revenue by Region (2020-2031)
3.6.3 China Market Sales, Revenue and Growth Rate (2020-2031)
3.6.4 Japan Market Sales, Revenue and Growth Rate (2020-2031)
3.6.5 South Korea Market Sales, Revenue and Growth Rate (2020-2031)
3.6.6 India Market Sales, Revenue and Growth Rate (2020-2031)
3.6.7 Southeast Asia Market Sales, Revenue and Growth Rate (2020-2031)
3.7 Latin America NAD+ Enhancer Market by Country
3.7.1 Latin America NAD+ Enhancer Market Sales by Country (2020-2031)
3.7.2 Latin America NAD+ Enhancer Market Revenue by Country (2020-2031)
3.7.3 Mexico Market Sales, Revenue and Growth Rate (2020-2031)
3.7.4 Brazil Market Sales, Revenue and Growth Rate (2020-2031)
3.8 Middle East and Africa NAD+ Enhancer Market by Country
3.8.1 Middle East and Africa NAD+ Enhancer Market Sales by Country (2020-2031)
3.8.2 Middle East and Africa NAD+ Enhancer Market Revenue by Country (2020-2031)
3.8.3 Turkey Market Sales, Revenue and Growth Rate (2020-2031)
3.8.4 Saudi Arabia Market Sales, Revenue and Growth Rate (2020-2031)
3.8.5 South Africa Market Sales, Revenue and Growth Rate (2020-2031)
4 NAD+ Enhancer Market Application Estimates & Trend Analysis
4.1 NAD+ Enhancer Market Application Dashboard
4.2 NAD+ Enhancer Market by Application
4.2.1 Hospitals
4.2.2 Clinics
4.2.3 Research Institutes
4.2.4 Other
4.3 Global NAD+ Enhancer Market Size by Application
4.3.1 Historical Analysis of Global NAD+ Enhancer Market Size by Application (2020-2025)
4.3.2 Projected Analysis of Global NAD+ Enhancer Market Size by Application (2026-2031)
5 NAD+ Enhancer Market Competitive Landscape Analysis
5.1 Global NAD+ Enhancer Leading Manufacturers’ Market Sales Performance and Share Analysis
5.2 Global NAD+ Enhancer Leading Manufacturers’ Market Revenue Performance and Share Analysis
5.3 Global NAD+ Enhancer Leading Manufacturers’ Average Sales Price (2020-2025)
5.4 Global NAD+ Enhancer Leading Manufacturers’ Regional Footprint (Headquarters, Manufacturing Base and Sales Ares)
5.5 Mergers and Acquisition Analysis
6 Leading Manufacturers’ Company Profiles
6.1 Chromadex
6.1.1 Chromadex Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.1.2 Chromadex Introduction and Business Overview
6.1.3 Chromadex NAD+ Enhancer Product Portfolio
6.1.4 Chromadex NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.2 Alive by Nature
6.2.1 Alive by Nature Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.2.2 Alive by Nature Introduction and Business Overview
6.2.3 Alive by Nature NAD+ Enhancer Product Portfolio
6.2.4 Alive by Nature NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.3 Life Extension
6.3.1 Life Extension Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.3.2 Life Extension Introduction and Business Overview
6.3.3 Life Extension NAD+ Enhancer Product Portfolio
6.3.4 Life Extension NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.4 Bulk Supplements
6.4.1 Bulk Supplements Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.4.2 Bulk Supplements Introduction and Business Overview
6.4.3 Bulk Supplements NAD+ Enhancer Product Portfolio
6.4.4 Bulk Supplements NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.5 NMN Bio
6.5.1 NMN Bio Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.5.2 NMN Bio Introduction and Business Overview
6.5.3 NMN Bio NAD+ Enhancer Product Portfolio
6.5.4 NMN Bio NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.6 Swanson Health
6.6.1 Swanson Health Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.6.2 Swanson Health Introduction and Business Overview
6.6.3 Swanson Health NAD+ Enhancer Product Portfolio
6.6.4 Swanson Health NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.7 Pure Nootropics
6.7.1 Pure Nootropics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.7.2 Pure Nootropics Introduction and Business Overview
6.7.3 Pure Nootropics NAD+ Enhancer Product Portfolio
6.7.4 Pure Nootropics NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.8 Thrivous
6.8.1 Thrivous Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.8.2 Thrivous Introduction and Business Overview
6.8.3 Thrivous NAD+ Enhancer Product Portfolio
6.8.4 Thrivous NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.9 BioTech Life Sciences
6.9.1 BioTech Life Sciences Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.9.2 BioTech Life Sciences Introduction and Business Overview
6.9.3 BioTech Life Sciences NAD+ Enhancer Product Portfolio
6.9.4 BioTech Life Sciences NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.10 Bioage
6.10.1 Bioage Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.10.2 Bioage Introduction and Business Overview
6.10.3 Bioage NAD+ Enhancer Product Portfolio
6.10.4 Bioage NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.11 Alitura Naturals
6.11.1 Alitura Naturals Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.11.2 Alitura Naturals Introduction and Business Overview
6.11.3 Alitura Naturals NAD+ Enhancer Product Portfolio
6.11.4 Alitura Naturals NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.12 Genex Formulas
6.12.1 Genex Formulas Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.12.2 Genex Formulas Introduction and Business Overview
6.12.3 Genex Formulas NAD+ Enhancer Product Portfolio
6.12.4 Genex Formulas NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.13 Prohealth
6.13.1 Prohealth Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.13.2 Prohealth Introduction and Business Overview
6.13.3 Prohealth NAD+ Enhancer Product Portfolio
6.13.4 Prohealth NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.14 LifeSeasons
6.14.1 LifeSeasons Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.14.2 LifeSeasons Introduction and Business Overview
6.14.3 LifeSeasons NAD+ Enhancer Product Portfolio
6.14.4 LifeSeasons NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.15 Renue By Science
6.15.1 Renue By Science Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.15.2 Renue By Science Introduction and Business Overview
6.15.3 Renue By Science NAD+ Enhancer Product Portfolio
6.15.4 Renue By Science NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.16 NOW Foods
6.16.1 NOW Foods Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.16.2 NOW Foods Introduction and Business Overview
6.16.3 NOW Foods NAD+ Enhancer Product Portfolio
6.16.4 NOW Foods NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.17 Tru Niagen (Chromadex)
6.17.1 Tru Niagen (Chromadex) Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.17.2 Tru Niagen (Chromadex) Introduction and Business Overview
6.17.3 Tru Niagen (Chromadex) NAD+ Enhancer Product Portfolio
6.17.4 Tru Niagen (Chromadex) NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.18 Elysium Health
6.18.1 Elysium Health Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.18.2 Elysium Health Introduction and Business Overview
6.18.3 Elysium Health NAD+ Enhancer Product Portfolio
6.18.4 Elysium Health NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.19 Tesseract Medical Research
6.19.1 Tesseract Medical Research Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.19.2 Tesseract Medical Research Introduction and Business Overview
6.19.3 Tesseract Medical Research NAD+ Enhancer Product Portfolio
6.19.4 Tesseract Medical Research NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.20 Quicksilver Scientific
6.20.1 Quicksilver Scientific Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.20.2 Quicksilver Scientific Introduction and Business Overview
6.20.3 Quicksilver Scientific NAD+ Enhancer Product Portfolio
6.20.4 Quicksilver Scientific NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.21 LifeVantage
6.21.1 LifeVantage Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.21.2 LifeVantage Introduction and Business Overview
6.21.3 LifeVantage NAD+ Enhancer Product Portfolio
6.21.4 LifeVantage NAD+ Enhancer Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
7 Industry Chain Analysis
7.1 Upstream Key Raw Materials
7.1.1 Raw Materials A Definition and Suppliers
7.1.2 Raw Materials B Definition and Suppliers
7.1.3 Raw Materials C Definition and Suppliers
7.2 NAD+ Enhancer Typical Downstream Customers
7.3 NAD+ Enhancer Sales Channel Analysis
8 Key Takeaways and Final Conclusions
9 Methodology and Sources
9.1 Research Methodology
9.2 Data Mining
9.2.1 Preliminary Data Sources
9.2.2 Secondary Sources
9.3 Industry Analysis Matrix
9.4 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.